Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement#Taiwan#Taipei#ADC#Mycenax_Biotech#RIN_Institute
Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement
Mycenax Biotech Inc. and Japan's RIN Institute have signed a licensing agreement to utilize RIN's proprietary linker technology for ADC development, enhancing therapeutic solutions.
third-news.com
October 31, 2025 at 7:08 AM
Mycenax Biotech and RIN Ink Licensing Agreement for ADC Advancement#Taiwan#Taipei#ADC#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology
Mycenax Biotech has signed a licensing agreement with RIN Institute to utilize its proprietary linker technology. This partnership aims to accelerate ADC development and offers enhanced therapeutic solutions.
third-news.com
October 31, 2025 at 7:07 AM
Mycenax Biotech Partners with RIN Institute to Advance ADC Development with Innovative Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute
Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology
Mycenax Biotech Inc. and Japan's RIN Institute team up through a license agreement to utilize innovative linker technology for developing advanced ADCs.
third-news.com
October 31, 2025 at 7:06 AM
Mycenax Biotech Partners with RIN to Enhance ADC Development Using Advanced Linker Technology#Taiwan#Taipei#ADC_Development#Mycenax_Biotech#RIN_Institute